Neurosilicon is a life science company advancing healthcare related research through enabling rapid, non-invasive, targeted excitation of excitable cells quickly and easily. Neurosilicon is privately held and was founded in March of 2005. Our
team is comprised of leading neuroscience researchers, engineers and experienced business leaders in technology commercialization. We work with top tier
partners in North America and Europe.